Presidential Communications Operations Office – Office of the Global Media and Public Affairs (PCOO-OGMPA)
MANILA, Philippines — The Department of Health (DOH) has not recorded any severe side effects experienced by the recipients of the 30,000 doses of the Sputnik V COVID-19 vaccine.
Some 30,000 doses of the jab developed by Russia’s Gamaleya have already been administered in the country, DOH Undersecretary Maria Rosario Vergeire said in a Laging Handa briefing on Saturday.
“Ito pong naibigay sa atin noon na Sputnik V, these were 30,000 doses, 100 percent po ay nai-deliver na do’n sa mga piling lugar dito sa NCR (National Capital Region) at lahat po ay nai-administer na for the first and second doses of this vaccine,” she said.
(The 30,000 doses of Sputnik V earlier delivered to us, 100 percent have already been distributed in certain areas in NCR and all of them have been administered for the first and second doses of this vaccine.)
“Ito pong mga adverse effects na tinatawag, wala po tayong naitala na severe at serious at mga namatay dito po sa Sputnik V na bakuna,” she added.
(We have not recorded any adverse effects that are severe or serious or have died from the Sputnik V vaccine.)
50K more doses
Meanwhile, Vergeire said that the 50,000 more doses to arrive in the Philippines this Sunday will be distributed to up to three “highly populous” areas which have recorded an increase in the number of COVID-19 infections.
“Kakaunti lang ho kasi itong parating na Sputnik V, mga 50,000 doses lang po so siguro po mga dalawa o tatlong lugar muna ang mabibigyan ng mga bakunang ito,” she added.
(The number of doses to arrive is a bit limited so we will probably give them to two or three areas.)
The arrival of the additional 50,000 doses would be the third delivery of the Sputnik V doses to arrive in the country.
The first batch of 15,000 doses arrived on May 1, while the second batch – a follow-up dose for the first shipment – arrived on May 12.
The Philippines is eyeing to procure a total of 20 million doses of Sputnik V.